Procter & Gamble Health Share Price

NSE: PGHL
|
Pharmaceuticals

₹ 5,237.50

-₹58.00 (-1.1%)
1D
Last updated 14 Oct, 2026, 15:29 IST

Procter & Gamble Health Share Price Today

As of 14 Oct 2026, Procter & Gamble Health share price is ₹5,237.50. The stock opened at ₹5,295.50, compared to its previous close of ₹5,295.50. During today's trading session, Procter & Gamble Health share price moved in the range of ₹5,205.50 to ₹5,384.00, with an average price of ₹5,294.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,707.00 and a high of ₹6,975.00. On the performance front, Procter & Gamble Health share price has increased by 6.42% over the last six months and is down 13.45% on a year-on-year basis.

₹5,205.50
1.10% down today
₹5,384.00
1D LOW
1D HIGH

Procter & Gamble Health Returns Calculator

Volume
14,032
Average traded price
₹5,235.55
Last traded time
03:29:54 14 Oct
Last traded quantity
2
Circuit
L
H
₹4,236.50
₹6,354.50
52-week
L
H
₹4,707.00
₹6,975.00
Mkt Cap Cr
8,752.85
P/E
24.53
P/B
16.69
ROA
42.42%
ROE
62.32%
ROCE
84.14%
Quick Ratio
1.65
EV/EBITDA
16.43
Based on fundamentals, this stock's
Step 4 of 5
Performance
Good
P & G Health Ltd outperforming most market indices
Step 1 of 5
Valuation
Overvalued
P & G Health Ltd appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,22,067.0135.035.0811.19%13.74%17.33%2.3121.42
Divis Laboratories2,46,222.1184.1814.6914.6%15.32%19.56%3.556.81
Torrent Pharmaceuticals1,76,300.5081.7720.964.87%25.49%13.85%0.7538.3
Zydus Lifesciences1,12,817.6824.574.168.57%18.59%17.35%0.9115.07
Laurus Labs1,11,898.66101.6420.9110.38%16.77%16.14%0.6854.71
Cipla1,06,129.9632.023.127.92%11.27%14.95%2.517.97
Dr. Reddy's Laboratories1,03,471.1432.52.725.48%11.07%12.54%1.3516.27
Mankind Pharma99,089.5247.326.07.36%11.74%13.13%0.7426.02
Aurobindo Pharma96,836.1026.12.566.34%9.25%11.76%1.1512.57
Lupin89,628.8316.153.9914.47%23.76%24.88%1.429.46

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About Procter & Gamble Health

ISIN
INE199A01012
Sector Market Cap
₹ 8,752.85 Cr

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.

Procter & Gamble Health Financial Highlights

  • Revenue: Procter & Gamble Health reported revenue of ₹1,425.31 crore in FY26 vs ₹944.52 crore in FY25. It showed an increase of 50.90% on a yearly basis.
  • Operating Profit: Procter & Gamble Health reported an operating profit of ₹449.86 crore in FY26 vs ₹311.62 crore in FY25. It showed an increase of 44.36% on a year-on-year basis.
  • Net Profit: Procter & Gamble Health reported a net profit of ₹326.91 crore in FY26 vs ₹234.41 crore in FY25. It showed an increase of 39.46% on a yearly basis.

Procter & Gamble Health Quarterly Result Highlights

  • Procter & Gamble Health reported revenue of ₹367.59 crore in Jun 2026, compared with ₹374.45 crore in Mar 2026, representing a decrease of 1.83% on a quarter-on-quarter (QoQ) basis.
  • Procter & Gamble Health reported an operating profit of ₹129.12 crore in Jun 2026, compared with ₹133.21 crore in Mar 2026, representing a decrease of 3.07% on a quarter-on-quarter (QoQ) basis.
  • Procter & Gamble Health reported a profit of ₹96.15 crore in Jun 2026, compared with ₹94.60 crore in Mar 2026, reflecting an increase of 1.64% on a QoQ basis.
  • The earnings per share (EPS) of Procter & Gamble Health stood at ₹141.00 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
51.82%
FII
6.33%
Other DII
3.39%
Retail and other
29.42%
Mutual funds
9.05%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20257.24%
Dec 20256.97%
Mar 20266.20%
Jun 20266.33%
1 day
+1.81%
1 week
-0.20%
1 month
-2.14%
1 year
-13.45%
3 years
+3.29%
5 years
-5.41%
Day
Open / Close
Change %
13 Oct 26
₹5,200.00 / ₹5,295.50
+1.81%
12 Oct 26
₹5,239.50 / ₹5,201.50
-0.07%
09 Oct 26
₹5,156.00 / ₹5,205.00
+0.94%
08 Oct 26
₹5,220.00 / ₹5,156.50
-1.48%
Show more

Procter & Gamble Health Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Revenue₹934.17₹1,151.26₹1,229.62₹1,114.41
Other Income₹10.35₹15.63₹18.39₹13.19
Total Revenue₹944.52₹1,166.89₹1,248.01₹1,127.60
Total Expenses₹632.90₹873.38₹933.81₹874.23
Profit Before Tax₹311.62₹273.32₹314.20₹253.37
Tax₹77.21₹72.34₹84.73₹60.85
Profit After Tax₹234.41₹200.98₹229.47₹192.52
EPS - Basic₹141.00₹121.00₹138.00₹116.00
EPS - Diluted₹141.00₹121.00₹138.00₹116.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Jun 2024Jun 2023
Profit before tax₹449.86₹311.62₹273.32₹314.20
Income before WC changes₹465.04₹323.82₹325.59₹355.69
Change in Assets-₹73.84-₹69.92₹70.57-₹97.15
Change in Liabilities₹50.44-₹3.89-₹82.68₹67.13
Change in WC-₹23.40-₹73.81-₹12.11-₹30.02
Cash flow from Operations₹337.79₹168.69₹228.29₹236.01
Cash flow from Investing₹1.26₹9.59-₹6.87-₹21.50
Cash flow from Financing-₹343.92-₹234.74-₹418.11-₹98.49
Total Cash Flow-₹4.87-₹56.46-₹196.69₹116.02
Cash (Start of the year)₹182.27₹238.73₹435.42₹319.40
Cash (End of the year)₹177.40₹182.27₹238.73₹435.42

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Non-Current Assets₹267.81₹270.14₹305.09₹280.08
Current Assets₹526.39₹524.22₹796.10₹608.04
Total Assets₹794.20₹794.36₹1,101.19₹888.12
Current Liabilities₹215.31₹218.91₹303.90₹231.90
Net Current Asset₹311.08₹305.31₹492.20₹376.14
Non-Current Liabilities₹41.93₹37.21₹46.40₹39.73
Equity Capital₹536.96₹538.24₹750.89₹616.49
Total Equity & Liabilities₹794.20₹794.36₹1,101.19₹888.12
* All values are in INR Crore
Qty
Bid
27
5232.5
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 27
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.82
Neutral
ATR (14)
164.64
Neutral
STOCH(9,6)
31.07
Neutral
STOCH RSI (14)
42.53
Neutral
ADX(9)
25
Bearish
UO(9)
43.62
Neutral
ROC(12)
-2.23
Bearish
WillR(14)
-76.41
Neutral
Period
Simple value
Exponential vaue
5D
5218.5
5254.45
10D
5331.75
5298.57
20D
5388
5389.17
50D
5668.39
5625.33
100D
6013.94
5721.44
Volume trend — traded volume by day
14 Oct0L
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Procter & Gamble Health
Pharmaceuticals
Add Stock
Add Another

Procter & Gamble Health Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.